Deoxyribose phosphate aldolase is required for development of hematopoietic stem cells in the zebrafish embryo
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dera knockdown may sensitize embryos to oxidative stress
leading to defective HSC development
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HSC developmental niche components are normal in dera morphants
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Expression for the neural crest and sclerotome
markers – crestin, foxc1a and foxc1b respectively
are similar between the uninjected and DeraMO
injected
groups
suggesting
that
HSC
development niche cells are normally patterned
and in their normal positions. This suggests that
defects in HSC development are not a result of
defects in HSC development niche construction.

Summary of Results
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The dera gene encodes a protein product that has been implicated in regulating the stress
response. Treatment of embryos with 30uM of sodium arsenite triggers oxidative stress and
this significantly reduces the expression of runx1 in the dorsal aorta. Treatment of DeraMO
injected embryos with 30uM of sodium arsenite enhances the loss of runx1 phenotype in
morphant embryos suggesting that loss of Dera protein expression leads to sensitization of
embryos to oxidative stress. Cycloheximide inhibits the stress response and mimics the
effect of arsenite treatment on Dera morphants. Green arrowhead = normal runx1 expression
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Vascular patterning, a pre-requisite for HSC development appears normal in
Dera knockdown
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Compared to the
uninjected embryos,
rag1 expression is
reduced in over
50% of the DeraMO
embryos and absent
in over 25%. Both
Cmyb and runx1
expression
(HSC
marker genes) were
significantly reduced
in the dorsal aorta of
DeraMO
6
ng
embryos
when
compared to the
uninjected
group.
Indicating that dera
is required for HSC
development. Green
arrowhead indicates
normal runx1, cmyb
or rag1 expression.
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dera is expressed in the embryonic vasculature

At 24hpf, dera is expressed in migrating neural crest cells (green arrowheads)
and in the embryonic vasculature, specifically the dorsal aorta (bounded by red
brackets.
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Hematopoietic stem cells (HSCs) are an integral part of modern biomedical research because
they are precursors to all blood cell lineages in vertebrates. Further understanding of
hematopoietic development will allow for improvements in the success of therapeutic bone
marrow transplantation; which is a crucial treatment in management of both malignant and nonmalignant blood disorders. Although HSC transplantation is curative for many blood disorders,
finding compatible donors is difficult due to a need for immunologic compatibility. Consequently,
recent research efforts have been directed towards generating HSCs for the patient, from the
patient themselves through the directed differentiation of induced pluripotent stem cells
(iPSCs). To achieve this overarching goal, it is imperative to have a thorough understanding of
genetics and molecular signals involved in the specification, determination, and differentiation
of HSCs during embryonic development so that this process can be replicated using patient
derived cells. In all vertebrates, hemogenic endothelium cells, located in the dorsal aorta floor,
are the origin of HSCs. Hemogenic endothelial must undergo an endothelial to hematopoietic
transition to become HSCs. Oxidative stress, as a result of glycolysis, is required for this
transition and to generate proliferating, quiescent, and differentiating HSCs. Deoxyribose
phosphate aldolase (Dera) is an enzyme that is involved in controlling the development of
stress granules in cells that are under stress. These stress granules are thought to play an
important role in mediating the stress response in cells. Dera is expressed in the embryonic
vasculature early in zebrafish development – at the time when HSCs first develop. Trunk
expression is present in the intermediate cell mass at 18 hours post fertilization (hpf) and in the
pronephric ducts, vasculature, and neural crest. Publicly available RNA sequencing data
suggests that dera might be somewhat enriched in the hemogenic endothelium. In this study,
we knocked down Dera expression in zebrafish embryos by antisense morpholino
oligonucleotide and examined expression of the conserved hematopoietic markers: runx1,
cmyb and rag1. We found a significant reduction in the expression of these markers, indicating
defective HSC development in dera morphant embryos. We further examined the expression of
markers of embryonic vasculature development in morphant embryos and found expression to
be normal suggesting that defective HSC development was not a result of abnormal vascular
patterning. We also conducted drug treatments with cycloheximide and sodium arsenite, at
varying concentrations, to determine if embryos are more sensitive to stress in the absence of
Dera. In conclusion, normal HSC development requires dera where its role is likely to moderate
the cellular stress response to keep it within physiological levels that are required for HSC
development.
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Dera is required for hematopoietic stem cell development

\
Abstract

13/13

Since HSCs arise from hemogenic
endothelium, normal patterning of the
embryonic vasculature is a prerequisite for normal HSC development.
DeraMO injected embryos exhibit
normal levels of gata1 expression
indicating normal primitive erythrocyte
development
(green
brackets).
DeraMO injected embryos also exhibit
normal
efnb2a
and
notch1b
expression
indicating
normal
patterning of the dorsal aorta and
hemogenic endothelium respectively
(red brackets).

• In DeraMO embryos which lack dera protein expression, the gene markers of HSC
development were significantly decreased which indicating that dera is crucial to the
developmental hematopoietic program.
• There were no phenotypic effects on the development of primitive erythrocytes or
embryonic vasculature as a result of the dera knockdown.
• DeraMO embryos exhibited a decrease in runx1 expression with arsenite treatment. This
phenotype was enhanced in the DeraMO embryo group having the least runx1
expression. Cycloheximide, an inhibitor of the stress response, reduced runx1 levels to
those similar to arsenite treated dera morphants. This suggests that Dera may regulate
the cellular stress response in the hemogenic endothelium during HSC development.
• Per the markers, the niche components associated with HSC were phenotypically and
functionally unaffected by the knockdown of Dera.wqq
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